Related by context. All words. (Click for frequent words.) 74 non splenectomized 68 unresectable recurrent 67 chronic idiopathic thrombocytopenic purpura 67 recurrent glioblastoma multiforme 66 metastatic dermatofibrosarcoma protuberans DFSP 66 myelodysplastic myeloproliferative diseases 66 pamidronate 65 chronic immune thrombocytopenic 64 mitoxantrone plus 64 decompensated liver disease 64 aggressive systemic mastocytosis 64 ® lenalidomide 63 immune thrombocytopenic purpura 63 elevated transaminases 63 unresectable locally advanced 63 severe renal impairment 63 purpura ITP 63 splenectomized 63 somatostatin analog 63 pediatric Crohn disease 63 hypereosinophilic syndrome 63 rheumatoid arthritis psoriatic arthritis 63 oropharyngeal candidiasis OPC 63 rheumatoid arthritis osteoarthritis ankylosing 63 metastatic malignant 63 metastatic gastric 63 Surgical resection 63 hepatorenal syndrome 63 R Saizen R 63 deep venous thromboses 62 R abatacept 62 idiopathic thrombocytopenic purpura 62 subependymal giant cell 62 neutropenia dehydration dyspnea 62 interferon alfa 2b 62 polycythemia vera essential thrombocythemia 62 anthracycline containing 62 Peginterferon alfa 2b 62 moderate renal impairment 62 unstable angina UA 62 vWD 62 HBeAg negative 62 essential thrombocythemia ET 62 unresectable 62 metastatic GIST 61 Certolizumab pegol 61 stage IIIb IV 61 relapsed MM 61 receptor tyrosine kinase inhibitor 61 Amgen Neulasta ® 61 autoantibody positive 61 leukemia AML 61 leukemia multiple myeloma 61 PEGylated anti 61 tumors GIST 61 LHRH receptor positive 61 mRCC 61 CTEPH 61 metastatic bladder 61 mild renal insufficiency 61 ACTEMRA TM 61 castrate resistant prostate cancer 61 nonmetastatic 61 stage IIIB 61 Myelodysplastic syndromes 61 taxane resistant 61 anthracycline taxane 61 de novo AML 61 psoriasis vulgaris 61 humanized interleukin 6 61 thetreatment 61 clodronate 61 pheochromocytoma 61 mild hepatic impairment 60 achieved ACR# 60 advanced medullary thyroid 60 TroVax ® 60 apremilast 60 osteopenic 60 adriamycin 60 folinic acid 60 minimally symptomatic 60 sorafenib Nexavar 60 weekly subcutaneous injections 60 Myelodysplastic Syndrome MDS 60 antithymocyte globulin 60 nucleoside analog 60 peginterferon alfa 60 AA Amyloidosis 60 baminercept 60 MAGE A3 ASCI 60 decompensated cirrhosis 60 immunomodulatory therapy 60 dasatinib Sprycel 60 xanthine oxidase inhibitor 60 bleeding pallor 60 PLX STROKE targeting 60 oral antidiabetic medication 60 RLAI 60 recurrent metastatic 60 Zavesca R 60 Clinically significant 60 salmeterol fluticasone 60 thrombocytopenic 60 papillary renal cell carcinoma 60 deletion 5q 60 non metastatic osteosarcoma 60 idiopathic thrombocytopenic purpura ITP 60 ZOLINZA 60 Stage IIIb 60 AGILECT R 60 retinal vein occlusion induced 60 HIV coinfected 60 systemic corticosteroid 60 dalteparin 60 imatinib Gleevec ® 60 somatostatin analogues 60 Refractory Hodgkin Lymphoma 60 Romiplostim 60 biliary tract cancer 60 KRAS mutations occur 60 Potiga 60 chronic thromboembolic pulmonary 60 FOLFOX6 59 Natalizumab 59 gastrointestinal stromal tumor GIST 59 5-FU/LV 59 mL/min/#.# m 2 59 Arranon 59 Heterozygous Familial Hypercholesterolemia 59 myeloid metaplasia 59 epithelial ovarian 59 androgen deprivation 59 active ankylosing spondylitis 59 Crohn disease CD 59 Kit CD# positive 59 GW# [003] 59 aspirin clopidogrel 59 pyrexia mucositis sepsis febrile 59 unresectable HCC 59 BARACLUDE ® 59 advanced hepatocellular carcinoma 59 lymphoid malignancies 59 hepatic metastases 59 recurrent genital herpes 59 BENICAR HCT 59 unresectable tumors 59 HBeAg + 59 abacavir lamivudine 59 alefacept 59 Zorbtive TM 59 metastatic hormone refractory 59 EGFR mutation positive 59 cell lymphoma CTCL 59 neurological manifestations 59 T1c 59 secondary hyperparathyroidism 59 diabetic gastroparesis 59 lenalidomide dexamethasone 59 SPRYCEL ® 59 unresectable stage 59 flutamide 59 Lenalidomide 59 comparator arm 59 corticosteroid dose 59 hematologic toxicity 59 FOLFIRI alone 59 advanced unresectable 59 emtricitabine tenofovir 59 bone marrow reticulin deposition 59 metastatic renal 59 chronic HCV genotype 59 stage IIIB IV 59 receiving XGEVA 59 HBeAg positive patients 59 chronic plaque psoriasis 59 multiple myeloma MM 59 plasma uric acid 59 Acute Myelogenous Leukemia AML 59 taxane chemotherapy 59 certolizumab 59 anticholinergic agents 59 HBeAg positive 59 lymphocytosis 59 non squamous histology 59 metastatic malignant melanoma 59 abacavir Ziagen 59 thrombocytosis 59 unresectable hepatocellular carcinoma HCC 59 surgically resectable 59 moderate hepatic impairment 59 thromboembolic events 59 induce orthostatic hypotension 59 squamous histology 59 romiplostim 59 EGFR TKI 59 adult chronic ITP 59 GnRH agonist 59 cetuximab Erbitux R 59 completely resected 59 refractory NSCLC 59 Papillary 59 HES CEL 59 dopamine partial agonist 59 corticotropin injection 59 saline placebo 59 Fludarabine 59 selective modulator 59 anagrelide 59 PD LID 59 portal vein thrombosis 59 smoldering myeloma 59 cutaneous manifestations 59 seropositive patients 58 Flu Cy 58 #mg ATC 58 docetaxel Taxotere R 58 efalizumab 58 allogeneic stem cell 58 IV NSCLC 58 primary immunodeficiency PI 58 milrinone 58 localized renal 58 primary humoral immunodeficiency 58 CLL SLL 58 Zavesca ® 58 Raptiva R 58 erlotinib Tarceva ® 58 oxycodone CR 58 Angiox R 58 chemoradiotherapy 58 immune thrombocytopenic purpura ITP 58 calcineurin inhibitor 58 Gleevec resistant 58 MULTAQ 58 #mg BID [001] 58 CsA 58 ritonavir boosted 58 thalidomide Thalomid 58 intravesical therapy 58 eosinophilic asthma 58 HP Acthar Gel repository 58 K ras mutations 58 metastatic renal cell carcinoma 58 neurogenic bladder 58 cytogenetic abnormalities 58 hormone refractory metastatic prostate 58 refractory colorectal cancer 58 heavily pretreated 58 tamoxifen Nolvadex ® 58 hyperphenylalaninemia HPA due 58 taxane refractory 58 cinacalcet 58 castrate resistant 58 Cimzia TM 58 juvenile idiopathic arthritis JIA 58 SNT-MC#/idebenone 58 exocrine pancreatic insufficiency EPI 58 refractory anaplastic astrocytoma 58 refractory acute myeloid 58 CIMZIA TM certolizumab pegol 58 peginterferon alfa 2b 58 recurrent NSCLC 58 Nexavar sorafenib 58 Helicobacter pylori eradication 58 8mg/kg 58 taxane chemotherapy administered 58 Ribavirin causes 58 leukopenia pancytopenia thrombocytopenia 58 5 fluorouracil leucovorin 58 prostate cancer CRPC 58 plus COPEGUS 58 levodopa induced 58 HIV HCV coinfected 58 MYLOTARG 58 visilizumab 58 PREZISTA r 58 severe exacerbations 58 onset diabetes mellitus 58 ZACTIMA 58 convulsive disorders 58 factor TNF 58 patients coinfected 58 upper limb spasticity 58 Interferon beta 58 lymphomas leukemias 58 elevated serum creatinine 58 artery stenosis 58 eltrombopag 58 INSPIRE Trial Phase III 58 oral clodronate 58 Known generically 58 #mg/day [001] 58 resistant hormone refractory 58 cutaneous T 58 mutated K ras 58 pT3 58 pegaptanib 58 metastatic renal cell 58 antiretroviral naïve 58 severe malignant osteopetrosis 58 onset idiopathic hypogonadism 58 progressive PsA 58 lipid elevations 58 quetiapine Seroquel 58 antiarrhythmic drugs 58 docetaxel Injection Concentrate 58 vinca alkaloid 58 mycophenolate mofetil 58 biologic DMARD 58 mCRC patients 58 EGFR expressing 58 AVODART 58 beta 1a 58 hypoparathyroidism 58 haematological malignancies 58 IBS C 58 lenalidomide Revlimid R 58 mycosis fungoides 58 antiarrhythmic 58 haematologic 58 ovarian carcinoma 58 receiving highly emetogenic 58 underwent resection 58 RoACTEMRA 58 Navelbine ® 58 hematopoietic cancers 58 EFFEXOR XR 58 BCG refractory carcinoma 57 anthracyclines taxanes 57 pancreatic insufficiency 57 Sprycel dasatinib 57 Anti VEGF 57 pulmonary exacerbations 57 candidemia 57 metastatic CRC 57 Mg Uk 57 receiving prophylactic anticoagulation 57 chronic ITP patients 57 Temsirolimus 57 previously untreated follicular 57 decitabine 57 Dementia Related Psychosis 57 generalized tonic clonic seizures 57 Folfox 57 stage IIIb 57 GH deficiency 57 PAOD 57 refractory chronic lymphocytic 57 CTAP# 57 refractory metastatic colorectal cancer 57 PROMACTA 57 NATRECOR R 57 pegylated liposomal doxorubicin 57 CLINICAL STUDIES 57 Aflibercept 57 ximelagatran 57 chronic periodontitis 57 known sulfonamide allergy 57 Cutaneous T 57 alpha interferons 57 TNF antagonist therapy 57 ribavirin therapy 57 occlusive disease 57 BRIM2 57 histologically confirmed 57 cyclophosphamide methotrexate 57 oral vancomycin 57 CrCl 57 denileukin diftitox 57 corticosteroids immunoglobulins 57 polycythemia vera PV 57 metastatic CRPC 57 nadroparin 57 TDF FTC 57 systemic hypotension 57 FluCAM arm 57 trastuzumab Herceptin ® 57 chronic rheumatic 57 HER2 expression 57 Gel repository corticotropin injection 57 fallopian tube carcinoma 57 situ CIS 57 TTF Therapy 57 neurodevelopmental impairment 57 Novartis Reclast 57 adverse cytogenetics 57 diagnosed glioblastoma multiforme 57 Tarceva TM 57 patients receiving myelosuppressive 57 motesanib 57 tenofovir emtricitabine 57 ORENCIA ® 57 CIMZIA R 57 q#h 57 Amrubicin 57 juvenile idiopathic arthritis 57 ibandronate 57 Aggrastat ® tirofiban hydrochloride 57 β blocker 57 acetonide FA 57 alendronate Fosamax 57 proliferative retinopathy 57 dasatinib Sprycel ® 57 metastatic carcinoma 57 zoledronate 57 primary dysmenorrhea 57 Adjuvant chemotherapy 57 Chronic lymphocytic leukemia 57 alemtuzumab treated 57 Fludara 57 SIADH 57 rituximab refractory 57 concomitant AEDs 57 locoregional disease 57 topically administered 57 acute mania 57 DMARDS 57 Vimpat R 57 prostate carcinoma 57 acute coronary syndromes ACS 57 transaminase elevations 57 Pemetrexed 57 Elitek 57 peripheral artery 57 hemorrhagic cystitis 57 infliximab monotherapy 57 alemtuzumab Campath 57 rhIGF-I/rhIGFBP-3 57 bisoprolol 57 maximally tolerated lipid lowering 57 estramustine 57 Bondronat 57 operable breast cancer 57 indinavir 57 ALT flares 57 malignant ascites 57 NPH insulin 57 anemia neutropenia 57 -#.# log# 57 MabThera Rituxan 57 resectable 57 glycoprotein IIb IIIa inhibitors 57 opioid tolerant 57 methotrexate monotherapy 57 treatmentof 57 administered concomitantly 57 FUSILEV enhances 57 mg TID 57 severe hepatic insufficiency 57 primidone 57 underwent liver transplantation 57 interferon alfa 2a 57 relapsed leukemia 57 immunocompetent adults 57 placebo dexamethasone 57 vandetanib 57 4mg/kg 57 mCRPC 57 stage IIIA 57 follicular lymphoma FL 57 resectable pancreatic cancer 57 cytopenias 57 severe oral mucositis 57 benign prostatic hypertrophy BPH 57 atazanavir ritonavir 57 refractory CTCL 57 hypogonadal 57 FOLFOX4 57 essential thrombocythemia 57 plus prednisone 57 alanine aminotransferase 57 SHPT 57 posaconazole 57 Pharmacokinetics PK 57 INVEGA ® 57 acute myeloid 57 lumbar spine BMD 57 gastrointestinal stromal tumors 57 asymptomatic carotid stenosis 56 Lubiprostone 56 pan HDAC inhibitor 56 reduce serum phosphate 56 erythropoietic 56 receiving immunosuppressive therapy 56 nilotinib Tasigna ® 56 HBeAg negative patients 56 metastatic castration resistant 56 adjuvant radiotherapy 56 infantile onset 56 gefitinib Iressa 56 TEMODAL 56 aspartate aminotransferase AST 56 Relapsed Refractory 56 chronic HBV 56 onabotulinumtoxinA 56 SYN# 56 transthyretin amyloidosis 56 pediatric acute lymphoblastic 56 Doxil ® 56 relapsed ALL 56 TNF antagonist 56 thymoma 56 follicular Non Hodgkin 56 relapsed refractory ALL 56 Velcade bortezomib 56 opioid naive 56 thyroid carcinoma 56 lymphoma CTCL 56 relapsed multiple myeloma 56 % CI #.#-#.# [007] 56 fluoropyrimidine 56 Stage IIB 56 goserelin 56 QTcF 56 Thal Dex 56 STELARA TM 56 Sanofi Aventis Taxotere 56 atherosclerotic renal artery stenosis 56 tirofiban 56 histologic subtype 56 reteplase 56 #.#mg/dL 56 posterior uveitis 56 biologic antibody 56 palifermin 56 forodesine 56 D aspartate NMDA receptor 56 HER2 overexpression 56 primary Restless Legs 56 generalized edema 56 genotypic resistance 56 relapsed CLL 56 interstitial pneumonitis 56 demonstrated antitumor activity 56 SIMPONI ® 56 metastatic pancreatic 56 Juvenile Idiopathic Arthritis 56 mildly symptomatic 56 protease inhibitor PI 56 methimazole 56 REMICADE ® 56 carboplatin paclitaxel 56 TNF alpha inhibitor 56 HER2 positive metastatic breast 56 MCF7 56 CYT# potent vascular disrupting 56 Orencia abatacept 56 PEGINTRON TM 56 differentiated thyroid 56 disease modifying antirheumatic 56 HBV infections 56 Ishak fibrosis score 56 administering XIFAXAN 56 de novo kidney transplant 56 null responder 56 myeloproliferative diseases 56 Eisenmenger syndrome 56 untreated multiple myeloma 56 recurrent glioblastoma 56 relapsed acute lymphoblastic 56 poor metabolizers 56 mcg BID 56 tolterodine ER 56 thymectomy 56 bladder ovarian 56 pegfilgrastim 56 nasopharyngitis headache 56 fistulizing Crohn disease 56 Myelodysplasia 56 LPV r 56 relapsed SCLC 56 SSc 56 volociximab 56 hormone receptor negative 56 adjunctive placebo 56 chemoresistant 56 FIRMAGON 56 Interferon beta 1b 56 Betaferon R 56 Vitrasert R 56 Sudhir Agrawal D.Phil 56 steroid refractory ulcerative 56 heparin induced thrombocytopenia 56 acute myelogenous leukemia AML 56 Actinic Keratosis 56 corticosteroid therapy 56 patientswith 56 Peginterferon Alfa 2a 56 palivizumab 56 euthyroid 56 gastrointestinal stromal tumor 56 COMBIVIR 56 transplantation HCT 56 tyrosine kinase inhibitor TKI 56 SGPT 56 caspofungin 56 invasive candidiasis 56 hypercalcemia 56 daunorubicin 56 underwent surgical resection 56 antibody MAb 56 polyneuropathy CIDP 56 breast carcinoma 56 Cervical Dystonia 56 Starlix 56 daily subcutaneous injections 56 colorectal cancer liver metastases 56 nonnucleoside reverse transcriptase inhibitors 56 biochemical recurrence 56 coinfected patients 56 veno occlusive disease 56 ocular hypertension 56 NATRECOR ® 56 cutaneous melanoma 56 Philadelphia Chromosome Positive 56 minimally symptomatic metastatic castrate 56 conventional DMARDs 56 GRN# 56 headache nasopharyngitis 56 3TC lamivudine Epivir 56 MabCampath 56 antiplatelet medications 56 EGFR tyrosine kinase inhibitor 56 galiximab 56 thyrotoxicosis 56 LEUKINE 56 Hazard Ratio 56 Hepatocellular Carcinoma HCC 56 mcg albinterferon alfa 2b 56 Atypical Hemolytic Uremic Syndrome 56 5mg dose 56 del 5q MDS 56 Nplate 56 Commonly prescribed 56 relapsed refractory multiple myeloma 56 adjunctive ABILIFY 56 injected subcutaneously 56 Dacogen decitabine 56 CTAP# Capsules 56 ARIXTRA 56 PNH patients 56 variceal bleeding 56 tipranavir ritonavir 56 KRAS wild 56 Telintra 56 headache abdominal pain 56 antiangiogenic therapy 56 plus prednisone prednisolone 56 RhuDex ® 56 #mg BID [003] 56 temsirolimus 56 diarrhea predominant irritable 56 Parnate 56 antiandrogen 56 diagnosed Ph + 56 basal cell carcinoma BCC 56 malabsorptive 56 VAPRISOL 56 Lymphocytic 56 NMIBC 56 chlorambucil 56 hereditary deficiency 56 metastatic lung cancer 56 antiandrogens 55 p#HER# positive 55 metastatic squamous cell carcinoma 55 unfavorable cytogenetics 55 gastric carcinoma 55 pancreatic adenocarcinoma 55 phakic intraocular lenses 55 Diamyd r 55 Chronic lymphocytic leukemia CLL 55 Angioedema 55 voriconazole 55 5 lipoxygenase inhibitor 55 metastatic uveal melanoma 55 Ceflatonin 55 baseline LDH 55 symptomatic BPH 55 colorectal carcinoma 55 refractory metastatic 55 FASLODEX 55 common hematologic malignancy 55 non squamous NSCLC 55 leukemia ALL 55 ARCOXIA 55 plus dexamethasone 55 bladder dysfunction 55 serum urate levels 55 metastatic androgen independent 55 R bisoprolol Euthyrox 55 TNF inhibitor 55 fludarabine cyclophosphamide 55 R metformin Concor 55 biochemical relapse 55 haematological toxicity 55 ankylosing spondylitis AS 55 Relapsed Refractory Multiple Myeloma 55 PASI scores 55 R entecavir 55 CIMZIA TM 55 fluorouracil leucovorin 55 tumor lysis syndrome 55 adenomatous 55 thrombocytopenic patients 55 FluCAM 55 Enzastaurin 55 refractory cutaneous T 55 prostate cancer HRPC 55 FAMPYRA 55 mycophenolate mofetil MMF 55 hematological parameters 55 kidney urologic 55 mg kg dose 55 painful diabetic neuropathy 55 premalignant lesion 55 leukemia CLL 55 plus 5-FU/LV 55 GSK# [001] 55 cancer mCRC 55 medullary thyroid cancer 55 ciclosporin 55 anthracycline therapy 55 imipenem 55 esophageal carcinoma 55 inhaled glucocorticoids 55 LV dysfunction 55 pain palliation 55 liver histology 55 Hematologic 55 HGPIN 55 molecular weight heparins 55 sorafenib tablets 55 Carotid endarterectomy 55 refractory Hodgkin 55 FRAGMIN 55 gemcitabine carboplatin 55 chronic angina 55 rotigotine transdermal patch 55 golimumab CNTO 55 EXJADE 55 TTR amyloidosis 55 symptomatic paroxysmal AF 55 g dl 55 vincristine doxorubicin 55 included exfoliative dermatitis 55 Fosamax alendronate 55 LATUDA 55 BEXXAR Therapeutic Regimen 55 KRAS mutant tumors 55 plus methotrexate 55 cutaneous T cell 55 fibrinolytic therapy 55 trastuzumab Herceptin R 55 achieved CCyR 55 Vincristine 55 Myelosuppression 55 FOLFIRI 55 infusional 5-FU/LV 55 Proxinium TM 55 receiving FUSILEV 55 verteporfin 55 Adjunctive 55 Hypokalemia 55 piperacillin tazobactam 55 symptomatic hyponatremia 55 formerly LymphoStat B 55 ribavirin RBV 55 levetiracetam Keppra 55 ara C 55 uremic pruritus 55 percutaneous drainage 55 pulmonary exacerbation 55 nilotinib 55 ritonavir boosted atazanavir 55 lopinavir r 55 FOLFOX 55 HBeAg seroconversion 55 ACOMPLIA R 55 prednisone prednisolone 55 Annamycin 55 skeletal metastases 55 Waldenstrom macroglobulinemia 55 mixed hyperlipidemia 55 APTIVUS r 55 IFN alfa 55 systemic autoimmune 55 tyrosine kinase inhibitors TKIs 55 myeloproliferative disorder 55 #mmHg [001] 55 lymphoma subtypes 55 refractory gastrointestinal stromal 55 RhuDex R 55 Diabetic Retinopathy DR 55 R adalimumab 55 aminotransferases 55 BARACLUDE r 55 Evoltra ® 55 systemic invasive fungal 55 Omacetaxine 55 NRTI backbone 55 ruboxistaurin 55 Kivexa 55 MIRAPEX ER 55 tibolone 55 assessing T DM1 55 malignant pleural mesothelioma 55 CHOP chemotherapy 55 MELAS 55 pharmacologic therapy 55 azacitidine 55 ertapenem 55 aPTT 55 anthracycline chemotherapy 55 RAPAMUNE 55 gemcitabine cisplatin 55 DOXIL 55 Heavy menstrual bleeding 55 hypomethylating agents 55 lopinavir r arm 55 gastric varices 55 IXEMPRA 55 benign prostatic hypertrophy 55 metastatic adenocarcinoma 55 SJIA 55 Subgroup analysis 55 idarubicin 55 anaplastic astrocytoma 55 progesterone receptor negative 55 antidiabetic drug 55 hepatotoxicity 55 intravenous cyclophosphamide 55 RhD positive 55 allogeneic HSCT 55 irbesartan 55 VELCADE melphalan 55 BRAF V# mutation 55 interferon ribavirin 55 Bezielle 55 gastrointestinal stromal tumors GIST 55 dilated cardiomyopathy DCM 55 squamous cell carcinoma SCC 55 advanced metastatic renal 55 Fingolimod 55 nucleoside naive 55 intracranial atherosclerosis 55 colorectal liver metastases 55 corifollitropin alfa 55 nonalcoholic steatohepatitis NASH 55 Hurthle cell 55 metastatic NSCLC 55 SSRI citalopram 55 alkylating agent 55 induce remission 55 Glioblastoma Multiforme GBM 55 nevirapine Viramune 55 Myelodysplastic syndromes MDS 55 SIMPONI TM 55 Free Survival PFS 55 chronic myeloid 55 medically inoperable 55 AZT zidovudine Retrovir 55 oxypurinol 55 Lactic acidosis 55 bortezomib refractory 55 untreated CLL 55 lymphocytic leukemia 55 Castration Resistant Prostate Cancer 55 dose escalation phase 55 squamous cell lung cancer 55 Severe Primary IGFD 55 Peg IFN 55 cisplatin gemcitabine 55 Akt inhibitor 55 systemic juvenile idiopathic 55 DAPT 55 untreated metastatic pancreatic 55 inhaled liposomal ciprofloxacin 55 dermatologic reactions 54 CIMZIA ™ 54 relapsing remitting MS RRMS 54 LEXIVA r 54 debulking surgery 54 investigational oral inhibitor 54 chemoradiation therapy 54 immunocompetent patients 54 acute leukemias 54 prostate cancer PCa 54 recurrent DVT 54 Sycrest 54 beclomethasone dipropionate 54 imatinib resistant 54 dacarbazine DTIC 54 hepatocellular cancer 54 IV bisphosphonates 54 Systemic Sclerosis 54 complement inhibitor eculizumab 54 trabectedin 54 relapsed Acute Myeloid 54 Simulect 54 dose cohort 54 fosamprenavir 54 azilsartan medoxomil 54 pancreatic resection 54 serum phosphate 54 melphalan prednisone 54 octreotide LAR 54 Etanercept 54 B CLL 54 vinorelbine tartrate 54 mIU L 54 romidepsin 54 diabetes mellitus DM 54 cardiovascular cerebrovascular 54 intra abdominal infections 54 CAELYX 54 histological subtype 54 affective psychosis 54 alfa 2a 54 papillary thyroid carcinoma 54 Acute Myeloid Leukaemia AML 54 Kineret R 54 pg ml 54 pyridostigmine 54 preoperative chemotherapy 54 KRAS status 54 chronic HCV 54 gestational hypertension 54 DMARDs 54 myelodysplastic syndromes MDS 54 CVD mortality 54 hypoxia activated prodrug 54 adjuvant cisplatin 54 Acute Myeloid Leukemia AML 54 Angiox ® 54 cytoreductive nephrectomy 54 cisplatin carboplatin 54 small lymphocytic lymphoma 54 undergoing peritoneal dialysis 54 Effexor venlafaxine 54 Laquinimod 54 hepatic encephalopathy HE 54 euvolemic hyponatremia 54 relapsed refractory AML 54 LHRH agonists 54 Bcr Abl T#I mutation 54 P = .# 54 HERCEPTIN 54 serum creatinine levels 54 hypomagnesemia 54 tapentadol ER 54 bevacizumab Avastin R 54 #mg/m# [001] 54 SUSTENNA TM 54 PKC# 54 % CI #.#-#.# [003] 54 hA# 54 EGFR expressing mCRC 54 refractory APL 54 metastatic liver 54 LUCENTIS 54 urothelial carcinoma 54 pneumocystis carinii pneumonia 54 serum calcium levels 54 Aptivus ® 54 complete cytogenetic response 54 antimetabolite 54 danazol 54 Sodium oxybate 54 osteosarcomas 54 osteoporotic vertebral compression fractures 54 recurrent squamous cell carcinoma 54 Avonex interferon beta 1a 54 Exelon rivastigmine 54 non mutated KRAS 54 generalized seizures 54 prostate cancer CaP 54 cetuximab Erbitux ® 54 colorectal liver 54 CP CPPS 54 NOLVADEX 54 vidofludimus 54 cortical dysplasia 54 multicenter Phase II 54 detemir 54 TAXOTERE R 54 μg liter 54 squamous cell histology 54 chemo radiotherapy 54 tuberous sclerosis TS 54 elevated ALT 54 radiotherapy RT 54 anti EGFR antibody 54 hematologic disorders 54 #mg/day [002] 54 administered subcutaneously 54 cholangiocarcinoma 54 serum aminotransferase levels